Matthew McManus insider trades

Open-market stock purchases and sales by Matthew McManus, President - Diag & Spatial Bio at BIO-TECHNE Corp, from SEC Form 4 filings since Aug 19, 2022.

Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -61%.

Recent trades

DateStockTradeValue
Feb 1, 2026TECH BIO-TECHNE CorpSold (not open market)$107K
Feb 1, 2026TECH BIO-TECHNE CorpBought (not open market)—

Companies traded

  • TECH BIO-TECHNE Corp: other filings, last Feb 1, 2026
  • AZTA Azenta, Inc: 1 buy, last Aug 19, 2022

Get free alerts when Matthew McManus files a new trade →